Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease

Neurology

Volumn 51, Issue 5, 1998, Pages 1381-1385

  Teipel, Stefan J ^a,b   Hampel, H ^a,b   Alexander, G E ^b   Schapiro, M B ^b   Horwitz, B ^b   Teichberg, D ^b   Daley, E ^b   Hippius, H ^a   Moller H J ^a   Rapoport, S I ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN DEGENERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; NERVE CELL DEGENERATION; PATIENT SELECTION; PRIORITY JOURNAL; WHITE MATTER;

EID: 0031797854     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.5.1381     Document Type: Article

References (35)

1. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlations with age and cerebrovascular risk factors. Stroke 1986;17:1084-1089.
2. Bradley WG, Waluch V, Brant-Zawadzki M, Yadley RA, Wycoff RR. Patchy periventricular white matter lesions in the elderly: a common observation during NMR imaging. Noninvasive Med Imaging 1984;1:35-41.
3. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26:1171-1177.
4. McDonald WM, Doraiswamy PM, Krishnan KRR. Magnetic resonance imaging hyperintensities in Alzheimer's disease. Arch Neurol 1991;48:468. Letter.
5. Brilliant M, Hughes L, Anderson D, Ghobrial M, Elble R. Rarefied white matter in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:39-46.
6. Fazekas F, Schmidt R, Offenbacher H, Chawluk JB, Alavi A. Magnetic resonance imaging hyperintensities in Alzheimer's disease. Arch Neurol 1991;48:468-469.
7. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992;32:164-169.
8. Bowen BC, Barker WW, Loewenstein DA, Sheldon J, Duara R. MR signal abnormalities in memory disorder and dementia. Am J Neuroradiol 1990;11:283-290.
9. Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski V. Lack of difference in brain hyperintensities between patients with early Alzheimer's disease and control subjects. Arch Neurol 1994;51:260-268.
10. Scheltens P, Barkhof F, Valk J, et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Brain 1992;115:735-748.
11. Cuénod C-A, Denys A, Michot J-L, et al. Amygdala atrophy in Alzheimer's disease: an in vivo magnetic resonance imaging study. Arch Neurol 1993;50:941-945.
12. Hampel H, Teipel SJ, Alexander GE, et al. Corpus callosum atrophy is a possible indicator for region and cell type specific neuronal degeneration in Alzheimer disease: an MRI analysis. Arch Neurol 1998;55:193-198.
13. Janowsky JS, Kaye JA, Carper RA. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J Am Geriatr Soc 1996;44:798-803.
14. Vermersch P, Roche J, Hamom M, et al. White matter magnetic resonance imaging hyperintensity in Alzheimer's disease: correlations with corpus callosum atrophy. J Neurol 1996;243:231-234.
15. Weis S, Jellinger K, Wenger E. Morphometry of the corpus callosum in normal aging and Alzheimer's disease. J Neural Transm 1991;33(suppl):35-38.
16. Yamanouchi H, Fukuyama H, Harada K, et al. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Arch Neurol 1993;50:1070-1074.
17. Biegon A, Eberling JL, Richardson BC, et al. Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol Aging 1994;15:393-397.
18. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
19. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Scheltens P, Barkhof F, Leys D, et al. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 1993;114:7-12.
21. Simon JH, Schiffer RB, Rudick RA, Herndon RM. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. Am J Neuroradiol 1987;8:599-604.
22. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991;180:215-221.
23. Pozzilli C, Bastianello S, Padovani A, Passafiume D. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex 1991;27:441-445.
24. Yamanouchi H, Sugiura S, Shimada H. Loss of nerve fibres in the corpus callosum of progressive subcortical vascular encephalopathy. J Neurol 1990;237:39-41.
25. Leys D, Soetaert G, Petit H, Fauquette A, Pruvo J-P, Steinling M. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-527.
26. DeCarli C, Murphy DGM, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
27. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-824.
28. Cowell PE, Turetsky BI, Gur RC, Grossman RI, Shtasel DL, Gur RE. Sex differences in aging of the human frontal and temporal lobes. J Neurosci 1994;14:4748-4755.
29. Salmon E, Maquet P, Sadzot B, Degueldre C, Lemaire C, Franck G. Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. Acta Neurol Belg 1991;91:288-295.
30. Pandya DN, Seltzer B. The topography of commissural fibres. In: Lepre F, Ptito M, Jasper HH, eds. Two hemispheres - one brain: functions of the corpus callosum. New York: Alan R. Liss, 1986:47-73.
31. de Lacoste MC, Kirkpatrick JB, Ross ED. Topography of the human corpus callosum. J Neuropath Exp Neurol 1985;44: 578-591.
32. Morrison JH, Scherr S, Lewis DA, Campbell MJ, Bloom FE. The laminar and regional distribution of neocortical somatostatin and neuritic plaques: implications for Alzheimer's disease as a global neocortical disconnection syndrome. In: Scheibel AB, Weschler AF, eds. The biological substrates of Alzheimer's disease. New York: Academic Press, 1986:115-131.
33. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987;7:1799-1808.
34. Glickstein M, Whitteridge D. Degeneration of layer III pyramidal cells in area 18 following destruction of callosal input. Brain Res 1976;104:148-151.
35. Jones EG. Laminar distribution of cortical efferent cells. In: Peters A, Jones EG, eds. Cerebral cortex: cellular components of the cerebral cortex, vol 1. New York: Plenum Press, 1984: 521-553.